Search Results - "Padilla-Rojas C"

Implementation of a SARS-CoV-2 genomic surveillance network as a strategy to face other health challenges in Peru.

Authors: Padilla-Rojas C Hurtado V Lizarraga W et al.

Source: Revista peruana de medicina experimental y salud publica [Rev Peru Med Exp Salud Publica] 2026 Mar 02; Vol. 43 (1), pp. 110-118. Date of Electronic Publication: 2026 Mar 02.

Publication Type: Journal Article

Journal Info: Publisher: Instituto Nacional de Salud Country of Publication: Peru NLM ID: 101227566 Publication Model: Electronic Cited Medium: Internet ISSN: 1726-4642 (Electronic) Linking ISSN: 17264634 NLM ISO Abbreviation: Rev Peru Med Exp Salud Publica Subsets: MEDLINE

Genomic epidemiology of SARS-CoV-2 in Peru from 2020 to 2024.

Authors: Sobkowiak B Langdon A Romero PE et al.

Source: Communications medicine [Commun Med (Lond)] 2026 Jan 09; Vol. 6 (1), pp. 22. Date of Electronic Publication: 2026 Jan 09.

Publication Type: Journal Article

Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) Subsets: PubMed not MEDLINE

Bispecific single-domain antibody (VHH) fused with human IgG1 Fc with dual specificity effectively neutralize Naja Kaouthia venom.

Authors: Pothisamutyothin, Kanokporn Sathorn, Sirisak Boonmee, Ratchana et al.

Source: PLoS Neglected Tropical Diseases. 3/17/2026, Vol. 20 Issue 3, p1-19. 19p.

Evolutionary and Modification Features of Two Monkeypox Virus Strains: Insights from Integrated Genomic and Epigenomic Analyses.

Authors: Zhao, Zhongru Zhang, Bohan Han, Jingwan et al.

Source: Viruses (1999-4915). Feb2026, Vol. 18 Issue 2, p259. 22p.

The Lambda Variant in Argentina: Analyzing the Evolution and Spread of SARS-CoV-2 Lineage C.37.

Authors: Nabaes Jodar, Mercedes Soledad Torres, Carolina Mojsiejczuk, Laura et al.

Source: Viruses (1999-4915). Jun2023, Vol. 15 Issue 6, p1382. 18p.

Notes from the Field: Dengue Outbreak - Peru, 2023.

Authors: Munayco CV Valderrama Rosales BY Mateo Lizarbe SY et al.

Source: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2024 Feb 01; Vol. 73 (4), pp. 86-88. Date of Electronic Publication: 2024 Feb 01.

Publication Type: Journal Article

Journal Info: Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic Cited Medium: Internet ISSN: 1545-861X (Electronic) Linking ISSN: 01492195 NLM ISO Abbreviation: MMWR Morb Mortal Wkly Rep Subsets: MEDLINE

Seroprevalence of SARS-CoV-2 antibodies in Ethiopia: findings from the 2022 national population-based survey (second round).

Authors: Tasew, Geremew Abdella, Saro Bejiga, Birra et al.

Source: BMC Infectious Diseases. 9/25/2025, Vol. 25 Issue 1, p1-13. 13p.

Development and Optimization of a Multiplex Real-Time RT-PCR to Detect SARS-CoV-2 in Human Samples.

Authors: Castellar-Mendoza, Camilo Calderón-Peláez, María-Angélica Castellanos, Jaime E. et al.

Source: International Journal of Microbiology. 3/11/2024, Vol. 2024, p1-6. 6p.

Epidemiological and clinical characteristics of Peruvian patients with mpox: A systematic review and meta-analysis.

Authors: León-Figueroa, Darwin A. Aguirre-Milachay, Edwin Diaz-Torres, Milagros et al.

Source: PLoS ONE. 6/25/2025, Vol. 20 Issue 6, p1-24. 24p.

Current and Future Spatial Distribution of the Aedes aegypti in Peru Based on Topoclimatic Analysis and Climate Change Scenarios.

Authors: Vergara, Alex J. Valqui-Reina, Sivmny V. Cieza-Tarrillo, Dennis et al.

Source: Insects (2075-4450). May2025, Vol. 16 Issue 5, p487. 18p.

Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease.

Authors: Díaz, Manolo Fernández Calderón, Katherine Rojas-Neyra, Aldo et al.

Source: Scientific Reports. 6/20/2022, Vol. 12 Issue 1, p1-18. 18p.

Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 Reinfections After a Second Wave With Predominance of Lambda in Lima and Callao, Peru.

Authors: Pampa-Espinoza, Luis Padilla-Rojas, Carlos Silva-Valencia, Javier et al.

Source: Open Forum Infectious Diseases. Jun2022, Vol. 9 Issue 6, p1-7. 7p.

Highly pathogenic avian influenza A (H5N1) virus outbreak in Peru in 2022-2023.

Authors: Sevilla N Lizarraga W Jimenez-Vasquez V et al.

Source: Infectious medicine [Infect Med (Beijing)] 2024 Apr 16; Vol. 3 (2), pp. 100108. Date of Electronic Publication: 2024 Apr 16 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier LTD on behalf of Tsinghua University Press Country of Publication: Netherlands NLM ID: 9918663679306676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-431X (Electronic) Linking ISSN: 2772431X NLM ISO Abbreviation: Infect Med (Beijing) Subsets: PubMed not MEDLINE

Early mutational signatures and transmissibility of SARS-CoV-2 Gamma and Lambda variants in Chile.

Authors: Oróstica, Karen Y. Mohr, Sebastian B. Dehning, Jonas et al.

Source: Scientific Reports. 7/11/2024, Vol. 14 Issue 1, p1-14. 14p.

Biosecurity and Vaccines for Emerging Aquatic Animal RNA Viruses.

Authors: Ahmadivand, Sohrab Savage, Ayanna Carla N. Phillips Palic, Dušan

Source: Viruses (1999-4915). Jun2025, Vol. 17 Issue 6, p768. 36p.

Description of a One-Year Succession of Variants of Interest and Concern of SARS-CoV-2 in Venezuela.

Authors: Jaspe, Rossana C. Loureiro, Carmen L. Sulbaran, Yoneira et al.

Source: Viruses (1999-4915). Jul2022, Vol. 14 Issue 7, pN.PAG-N.PAG. 10p.

Soluble Activin Receptor Type IIB Improves Muscle Regeneration Following Crotalus atrox Venom-Induced Damage.

Authors: Sonavane, Medha Alqallaf, Ali Mitchell, Robert D. et al.

Source: Toxins. Feb2025, Vol. 17 Issue 2, p59. 19p.

Antivenom potential of chitosan gold nanoparticles.

Authors: Saha, Kanchan Sarkhel, Sumana

Source: Indian Journal of Experimental Biology. Jan2025, Vol. 63 Issue 1, p76-85. 10p.

SARS-CoV-2 Lambda and Omicron Variants: Antigenicity Evaluation of Spike Proteins as Potential Targets for Vaccine Development.

Authors: Zarei, Mahboubeh Zakeri, Alireza Khalili, Saeed et al.

Source: Vaccine Research. 2023, Vol. 10 Issue 1, p1-5. 5p.

Risk and severity of SARS-CoV-2 reinfection among patients with multiple sclerosis vs. the general population: a population-based study.

Authors: Barzegar, Mahdi Manteghinejad, Amirreza Bagherieh, Sara et al.

Source: BMC Neurology. 10/8/2022, Vol. 22 Issue 1, p1-10. 10p.